Cramer Trust Plans to Trim Cardinal, Lilly Stakes
The charitable trust tied to Jim Cramer plans to sell portions of its Cardinal Health and Eli Lilly shares after both stocks rallied more than 20% since late September.
Updated on Nov. 7, 2026 in Healthcare
Jim Cramer's Charitable Trust plans to sell 50 Cardinal Health shares at about $273 each and 10 Eli Lilly shares at about $1,420 each. Both stocks have risen more than 20% since late September, after stronger-than-expected results and raised outlooks.
Why it matters
The planned sales show how a portfolio that holds health care stocks as a diversifier against data-center exposure is rebalancing after a strong run. The trades also reflect how health care outperformed technology shares on Thursday.
The trust would sell 50 Cardinal Health shares bought in March 2026, realizing a 20% gain, and 10 Eli Lilly shares bought in February 2022, realizing a 500% gain. After the sales, it would hold 375 Cardinal Health shares and 70 Eli Lilly shares.
The players
Jim Cramer
Jim Cramer is a television financial commentator and host known for his stock picks and market commentary, whose charitable trust holds the portfolio described in this story.
Cardinal Health
Cardinal Health is a large American healthcare services and pharmaceutical distribution company that operates across the U.S. healthcare supply chain.
Eli Lilly
Eli Lilly is a major American pharmaceutical company known for its diabetes and obesity treatments, including tirzepatide.
The details
Cardinal Health rose more than 4% Thursday after stronger-than-expected earnings and a raised full-year outlook. Eli Lilly was modestly higher after stronger-than-expected results and an outlook increase last week, as health care stocks outperformed technology and data-center shares.
Timeline
February 2022: Eli Lilly shares were bought, with 10 shares now planned for sale.
March 2026: Cardinal Health shares were bought, with 50 shares now planned for sale.
Late September 2026: Both stocks began a rally that has since exceeded 20%.
Last week: Eli Lilly reported stronger results and raised its outlook.
Thursday, November 5, 2026: Cardinal Health rose after earnings as the trades were reported.
Market Landscape
The trust's planned trades come as health care stocks outperformed technology and data-center shares on Thursday, a rotation the trust cites as its reason for holding health care names. Its move to trim after a 20%-plus rally reflects the rebalancing that follows such a divergence.
Individual investors can see how a widely followed portfolio is rebalancing after a strong rally in two health care names. Readers weighing similar positions can compare the trust's stated diversification logic against their own exposure to technology and data-center stocks.
The takeaway
Strong earnings and raised outlooks can prompt rebalancing even for long-held positions. Investors who hold concentrated sector bets may review whether a rally has pushed weightings past their targets.
Further reading
For more on the sector, see Healthcare coverage of drugmakers and distributors.
Source note: This article includes information reported by TokenPost.
